Search research articles
Contact Us
Filters
Showing results (351-360 of 643) with videos related to
Page
of 65
Sort By:
Database : the Journal of Biological Databases and Curation
|
April 11, 2015
Using Ontology Fingerprints to disambiguate gene name entities in the biomedical literature
Guocai Chen, Jieyi Zhao, Trevor Cohen, et al.
Annals of Surgical Oncology
|
October 8, 2011
Prospective evaluation of the nipple-areola complex sparing mastectomy for risk reduction and for early-stage breast cancer
Jamie L Wagner, Regina Fearmonti, Kelly K Hunt, et al.
The Oncologist
|
March 26, 2025
A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies
Jibran Ahmed, Anne Knisely, Carlos Torrado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2025
HER2-Positivity as a Prognostic Biomarker and Therapeutic Target in Advanced Biliary Tract Cancer: A Multi-Institutional Analysis
Sunyoung S Lee, Dong Hyun Seo, Taek Chung, et al.
Molecular Cancer
|
March 27, 2024
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study
Blessie Elizabeth Nelson, Jason Roszik, Jibran Ahmed, et al.
Targeted Oncology
|
September 24, 2021
A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer
Kathleen N Moore, David S Hong, Manish R Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2021
Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive Cancer
Ming Zhao, Stephen Scott, Kurt W Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2021
Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas
Funda Meric-Bernstam, Randy F Sweis, F Stephen Hodi, et al.
Oncotarget
|
May 8, 2018
Targeted next generation sequencing of well-differentiated/dedifferentiated liposarcoma reveals novel gene amplifications and mutations
Neeta Somaiah, Hannah C Beird, Andrea Barbo, et al.
Cancer
|
December 8, 2005
Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy
Linda J Adepoju, W Fraser Symmans, Gildy V Babiera, et al.
Page
of 65
Search research articles
Search
Showing results (351-360 of 643) with videos related to
Sort By:
Page
of 65
Database : the Journal of Biological Databases and Curation
|
April 11, 2015
Using Ontology Fingerprints to disambiguate gene name entities in the biomedical literature
Guocai Chen, Jieyi Zhao, Trevor Cohen, et al.
Annals of Surgical Oncology
|
October 8, 2011
Prospective evaluation of the nipple-areola complex sparing mastectomy for risk reduction and for early-stage breast cancer
Jamie L Wagner, Regina Fearmonti, Kelly K Hunt, et al.
The Oncologist
|
March 26, 2025
A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies
Jibran Ahmed, Anne Knisely, Carlos Torrado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2025
HER2-Positivity as a Prognostic Biomarker and Therapeutic Target in Advanced Biliary Tract Cancer: A Multi-Institutional Analysis
Sunyoung S Lee, Dong Hyun Seo, Taek Chung, et al.
Molecular Cancer
|
March 27, 2024
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study
Blessie Elizabeth Nelson, Jason Roszik, Jibran Ahmed, et al.
Targeted Oncology
|
September 24, 2021
A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer
Kathleen N Moore, David S Hong, Manish R Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2021
Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive Cancer
Ming Zhao, Stephen Scott, Kurt W Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2021
Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas
Funda Meric-Bernstam, Randy F Sweis, F Stephen Hodi, et al.
Oncotarget
|
May 8, 2018
Targeted next generation sequencing of well-differentiated/dedifferentiated liposarcoma reveals novel gene amplifications and mutations
Neeta Somaiah, Hannah C Beird, Andrea Barbo, et al.
Cancer
|
December 8, 2005
Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy
Linda J Adepoju, W Fraser Symmans, Gildy V Babiera, et al.
Page
of 65